DSIP-CBBBP Fusion Peptide BBB Delivery Research (2024) The 2024 Frontiers in Pharmacology study by Shao and colleagues investigated a DSIP-CBBBP (cell-penetrating peptide) fusion construct expressed in Pichia pastoris in a PCPA-induced insomnia mouse model
Other GLP-1 and dual-agonist agents, including tirzepatide, are also in wide use, though not every GLP-1 on the market carries an FDA weight loss indication
[DOI] [PMC free article] [PubMed] [Google Scholar] 53.Wang M., Zhou Y., Hao G., Wu Y.E., Yin R., Zheng Y., Zhao W
The care team is accessible throughout treatment - for questions, shipping issues, dosage concerns, or plan adjustments
Non-surgical options such as fillers, skin tightening, or laser can assist
Nutrients 14, 3940 10.3390/nu14193940 [DOI] [PMC free article] [PubMed] [Google Scholar] 9.B A